Related Experiment Video
Updated: Jun 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Dealing with heterogeneity between cohorts in genomewide SNP association studies
Jeremie J Lebrec1, Theo Stijnen, Hans C van Houwelingen
1Leiden University Medical Center, The Netherlands. j.j.p.lebrec@lumc.nl
Genomewide association studies (GWAS) can improve detection of genetic variants by exploiting cohort heterogeneity. A novel testing strategy enhances the ability to find important genetic variants influencing complex diseases.
Area of Science:
- Genetics
- Bioinformatics
- Statistical Genetics
Background:
- Genomewide association studies (GWAS) require large sample sizes for statistical power, often necessitating data pooling across diverse cohorts.
- Classical meta-analytic methods are typically employed for combining GWAS data, but may overlook population-specific genetic effects.
- Heterogeneity in association measures across cohorts is expected in genetic studies.
Purpose of the Study:
- To demonstrate a novel method for leveraging cohort heterogeneity to enhance the detection of influential genetic variants in GWAS.
- To explore the utility of pathway analysis using summary data for resolving heterogeneity in GWAS.
- To address the limitations of standard GWAS methods in identifying heterogeneous genetic variants associated with complex diseases.
Main Methods:
- Development of a new statistical testing strategy designed to exploit heterogeneity in association measures across different cohorts.
- Application of pathway analysis techniques to summary data to investigate and resolve observed heterogeneity.
- Comparison of the proposed method against standard meta-analytic approaches used in GWAS.
Main Results:
- The proposed testing strategy successfully identifies influential genetic variants that may be missed by standard GWAS meta-analysis methods.
- Exploiting heterogeneity can significantly improve the power to detect important genetic variants.
- Pathway analysis aids in understanding and resolving heterogeneity, providing deeper biological insights.
Conclusions:
- A novel testing strategy effectively utilizes cohort heterogeneity to improve the discovery of genetic variants in GWAS.
- This approach enhances the detection of heterogeneous but significant genetic variants associated with complex diseases.
- The findings suggest a more sensitive method for genetic discovery in large-scale association studies.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Genetic Variation
Genes exist in different versions called alleles, which...
